The clinical trial is designed to evaluate the safety, tolerability and preliminary efficacy of Incyte’s oral indoleamine dioxygenase-1 (IDO1) inhibitor, INCB24360, in combination with Genentech’s PD-L1 immune checkpoint
In many countries, aflibercept solution for injection has already been approved as EYLEA to treat patients with neovascular age-related macular degeneration (wet AMD) and visual impairment due to
Under the deal, Pfizer will acquire a portion of Baxter’s facility in Orth, Austria, and will also have access to Baxter’s meningitis vaccine, NeisVac-C, and its encephalitis vaccine,
The European approval applies to all European Union (EU) member states, as well as Iceland and Norway. In the EU, Eliquis is also approved to prevent venous thromboembolism
The project, funded by the PATH malaria vaccine initiative (MVI), will see Burnet use its new technology and ARTES’s patented Metavax platform for developing the new type of
The company’s PFS is designed as a low cost alternative to other auto-injectors in the market and it offers two single dose syringes of epinephrine, which is considered
The FDA clearance allows the company to start expanding its clinical investigation of PROHEMA into rare, non-malignant disorders. The company intends to start enrollment of the Phase Ib
Tanzeum is a once weekly option for patients, in combination with some other glucose-lowering medicines. In April 2014, the drug was approved by the US Food and Drug
Gazyvaro, a new, type II, glycoengineered monoclonal antibody, is marketed as Gazyva outside of the EU and Switzerland. It is designed to attach to CD20, a protein found
The collaboration is aimed at developing new medicines for improved treatment of patients with cardio-metabolic diseases. First agreement between the two companies was signed in June 2011, which
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.